Search
Fraunhofer Institute for Toxicology and Experimental Medicine
Fraunhofer Institute for Toxicology and Experimental Medicine
Events
Press and media
Career
Contact
Deutsch
Institute
[X]
Institute
Organizational structure
Institute director
Quality assurance
Our network
Institute chronicles
Board of trustees
Fraunhofer Mission
Services and Expertise
[X]
Services and Expertise
Drug Development
GMP manufacturing of biopharmaceuticals for clinical trials
Regulatory research and risk assessment in drug development
Preclinical research and testing
Efficacy
Toxicology testing
Clinical trials
Chemical safety and assessment
Method development and customized analyses
Toxicology testing
Exposure characterization
Regulatory research and risk assessment
Translational Biomedical Engineering
Device development and fabrication processes
Testing and test methods
Regulatory support
Personalized Tumor Therapy
Single-cell analytics
Enrichment, isolation and molecular analysis of rare cells
Decoding single cells
Innovative tumor models
In-vitro and in-vivo drug testing
Advanced preclinical PDX models
Mathematical modeling and bioinformatics
Multi-level disease modeling
Bioinformatics services and consulting
Focuses of Research
[X]
Focuses of Research
Drug Development
Testing of cell-based medicinal products
Controlling antibiotic-resistant pathogens
Human lung tissue for research on respiratory diseases
Non-invasive breath gas analysis
Development of novel biomarkers for use in clinical trials
Clinical and translational fibrosis research
Imaging of the human lung - visualizing drug efficacy
Chemical Safety and Assessment
Exposure science
Non-animal toxicology testing
Toxicity of fibers, particles, and nanomaterials
Analysis of indoor and workplace air quality
Translational Biomedical Engineering
Innovative approaches for inhaled aerosol therapies
Medical and environmental sensors
Accelerated life cycle testing
Personalized Tumor Therapy
Single-cell technologies
Identification of target structures and therapy prediction
Mathematical modeling of disease processes
Models of treatment and metastasis formation
CRC Hannover
Lighthouse projects
[X]
Lighthouse projects
High-Performance Center Translational Biomedical Engineering
German-Australian iCAIR project
"Phage4Cure": bacteriophages as an approved drug
EU-ToxRisk: toxicological risk assessment
Press and media
[X]
Press and media
Newsletter
Annual reports
Publications
Press releases
PM CPA Takeda
PM Bereich Personalisierte Tumortherapie
PM Nature Papers
Change in management 2017
Center Inauguration
New EU regulation on medical devices
eTRANSAFE – collaborative research project aimed at improving safety in the drug development process
iCAIR
Initiative Wissenschaft
Phage4Cure
German-Australian project iCAIR
Proof-of-Concept-Initiative
Fraunhofer researcher Prof. Christoph Klein received the “Fidler Innovation Award”
Science Campus 2018
InnoHealth Australia 2017-2019
Medical Device Regulation
Synergy Boost
InnoHealth Australia 2017-2019
Gentle treatment for premature babies with lung diseases
Print media
Thematic Flyers
Brochures
News
Fraunhofer ITEM scientists won prizes at the 5th DZL Annual Meeting
Poster prize to Fraunhofer ITEM scientist
Our Project Group on Personalized Tumor Therapy is now ISO 9001 certified
Testing of a novel anti-inflammatory drug for treating COPD based on endotoxin challenge
Poster prize to Fraunhofer ITEM scientist
Thematic Flyers
Events
[X]
Events
Looking back at “Models of Lung Disease” 2018
Career
[X]
Career
Professionals
Postgraduates
Undergraduates
Working at Fraunhofer
Contact
More
Where am I?
English
Sitemap
Sitemap
Expand section
Close section
Institute
Expand / Hide
Organizational structure
Institute director
Quality assurance
Our network
Institute chronicles
Board of trustees
Fraunhofer Mission
Expand section
Close section
Services and Expertise
Expand / Hide
Drug Development
Expand / Hide
GMP manufacturing of biopharmaceuticals for clinical trials
Regulatory research and risk assessment in drug development
Preclinical research and testing
Expand / Hide
Efficacy
Toxicology testing
Clinical trials
Chemical safety and assessment
Expand / Hide
Method development and customized analyses
Toxicology testing
Exposure characterization
Regulatory research and risk assessment
Translational Biomedical Engineering
Expand / Hide
Device development and fabrication processes
Testing and test methods
Regulatory support
Personalized Tumor Therapy
Expand / Hide
Single-cell analytics
Expand / Hide
Enrichment, isolation and molecular analysis of rare cells
Decoding single cells
Innovative tumor models
Expand / Hide
In-vitro and in-vivo drug testing
Advanced preclinical PDX models
Mathematical modeling and bioinformatics
Expand / Hide
Multi-level disease modeling
Bioinformatics services and consulting
Expand section
Close section
Focuses of Research
Expand / Hide
Drug Development
Expand / Hide
Testing of cell-based medicinal products
Controlling antibiotic-resistant pathogens
Human lung tissue for research on respiratory diseases
Non-invasive breath gas analysis
Development of novel biomarkers for use in clinical trials
Clinical and translational fibrosis research
Imaging of the human lung - visualizing drug efficacy
Chemical Safety and Assessment
Expand / Hide
Exposure science
Non-animal toxicology testing
Toxicity of fibers, particles, and nanomaterials
Analysis of indoor and workplace air quality
Translational Biomedical Engineering
Expand / Hide
Innovative approaches for inhaled aerosol therapies
Medical and environmental sensors
Accelerated life cycle testing
Personalized Tumor Therapy
Expand / Hide
Single-cell technologies
Identification of target structures and therapy prediction
Mathematical modeling of disease processes
Models of treatment and metastasis formation
CRC Hannover
Expand section
Close section
Lighthouse projects
Expand / Hide
High-Performance Center Translational Biomedical Engineering
German-Australian iCAIR project
"Phage4Cure": bacteriophages as an approved drug
EU-ToxRisk: toxicological risk assessment
Expand section
Close section
Press and media
Expand / Hide
Newsletter
Annual reports
Publications
Press releases
Expand / Hide
PM CPA Takeda
PM Bereich Personalisierte Tumortherapie
PM Nature Papers
Change in management 2017
Center Inauguration
New EU regulation on medical devices
eTRANSAFE – collaborative research project aimed at improving safety in the drug development process
iCAIR
Initiative Wissenschaft
Phage4Cure
German-Australian project iCAIR
Proof-of-Concept-Initiative
Fraunhofer researcher Prof. Christoph Klein received the “Fidler Innovation Award”
Science Campus 2018
InnoHealth Australia 2017-2019
Medical Device Regulation
Synergy Boost
InnoHealth Australia 2017-2019
Gentle treatment for premature babies with lung diseases
Print media
Expand / Hide
Thematic Flyers
Brochures
News
Expand / Hide
Fraunhofer ITEM scientists won prizes at the 5th DZL Annual Meeting
Poster prize to Fraunhofer ITEM scientist
Our Project Group on Personalized Tumor Therapy is now ISO 9001 certified
Testing of a novel anti-inflammatory drug for treating COPD based on endotoxin challenge
Poster prize to Fraunhofer ITEM scientist
Thematic Flyers
Expand section
Close section
Events
Expand / Hide
Looking back at “Models of Lung Disease” 2018
Expand section
Close section
Career
Expand / Hide
Professionals
Postgraduates
Undergraduates
Working at Fraunhofer
Contact